Ximingting Tablet
- Generic Name
- Ximingting Tablet
Multi-centre Clinical Trial on Hormone Replacement Treatment in China
Phase 4
- Conditions
- Menopausal SyndromeCardiovascular DiseaseOsteoporosisBreast Cancer
- Interventions
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2012-10-02
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 1200
- Registration Number
- NCT01698164
- Locations
- 🇨🇳
PUMCH, Peking, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath